Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Aveanna Healthcare Holdings (AVAH) EPS (Weighted Average and Diluted) (2020 - 2026)

Aveanna Healthcare Holdings' EPS (Weighted Average and Diluted) history spans 7 years, with the latest figure at $0.83 for Q1 2026.

  • For Q1 2026, EPS (Weighted Average and Diluted) rose 453.33% year-over-year to $0.83; the TTM value through Jan 2026 reached $1.05, up 1850.0%, while the annual FY2026 figure was $1.05, 1850.0% up from the prior year.
  • EPS (Weighted Average and Diluted) reached $0.83 in Q1 2026 per AVAH's latest filing, up from $0.06 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.83 in Q1 2026 to a low of -$2.56 in Q3 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.21, with a median of $0.03 recorded in 2025.
  • The largest YoY upside for EPS (Weighted Average and Diluted) was 1200.0% in 2022 against a maximum downside of 25700.0% in 2022.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$1.28 in 2022, then skyrocketed by 89.06% to -$0.14 in 2023, then skyrocketed by 207.14% to $0.15 in 2024, then plummeted by 60.0% to $0.06 in 2025, then surged by 1283.33% to $0.83 in 2026.
  • Per Business Quant, the three most recent readings for AVAH's EPS (Weighted Average and Diluted) are $0.83 (Q1 2026), $0.06 (Q3 2025), and $0.13 (Q2 2025).